Synribo

Omacetaxine Mepesuccinate

7.8 High risk

Synribo & White blood cell count decreased

20.9%

of users reported White blood cell count decreased

50.0%

also reported Severe reaction

56.5%

are women

Most common medical consequences

Severe reaction
50.0%
Hospitalization
38.5%
Death
11.5%

Have you experienced any negative side effects from this medication?

Synribo: general information

Most common side effects (12)

Most commonly affected ages

30 - 39 years
12.9%
40 - 49 years
6.5%
50 - 59 years
31.0%
60 - 69 years
25.8%
70 - 79 years
23.9%
On this page
Synribo & White blood cell count decreased
Synribo: general information